Pharmacokinetics and pharmacodynamics of nasally delivered midazolam

British Journal of Clinical Pharmacology

Volumn 69, Issue 6, 2010, Pages 607-616

  Haschke, Manuel ^a   Suter, Katja ^a   Hofmann, Sarah ^a   Witschi, Robert ^a   Fröhlich, Johannes ^b   Imanidis, Georgios ^c   Drewe, Jürgen ^a   Briellmann, Thomas A ^c   Dussy, Franz E ^c   Krähenbühl, Stephan ^a   Surber, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Akroswiss AG   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

1 hydroxymidazolam; Chitosan; Cyclodextrin; Midazolam; Nasal application; Pharmacokinetics

Indexed keywords

ALPHA HYDROXYMIDAZOLAM; BETA CYCLODEXTRIN; CAVASOL; CHITOSAN; MIDAZOLAM; MIDAZOLAM MALEATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; LOW DRUG DOSE; MALE; NORMAL HUMAN; NOSE IRRITATION; NOSE MUCOSA; OPEN STUDY; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; REACTION TIME; SINGLE DRUG DOSE; VISUAL ANALOG SCALE;

EID: 77952080526     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03611.x     Document Type: Article

References (27)

1. Lahat E, Goldman M, Barr J, Bistritzer T, Berkovitch M. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. BMJ (Clin Res Ed) 2000 321 : 83 6. (Pubitemid 30438483)
2. Mahmoudian T, Zadeh MM. Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children. Epilepsy Behav 2004 5 : 253 255. (Pubitemid 38461216)
3. Harbord MG, Kyrkou NE, Kyrkou MR, Kay D, Coulthard KP. Use of intranasal midazolam to treat acute seizures in paediatric community settings. J Paediatrics Child Health 2004 40 : 556 558. (Pubitemid 39387553)
4. Scheepers M, Scheepers B, Clarke M, Comish S, Ibitoye M. Is intranasal midazolam an effective rescue medication in adolescents and adults with severe epilepsy? Seizure 2000 9 : 417 422.
5. Bjorkman S, Rigemar G, Idvall J. Pharmacokinetics of midazolam given as an intranasal spray to adult surgical patients. Br J Anaesth 1997 79 : 575 580. (Pubitemid 27493664)
6. Burstein AH, Modica R, Hatton M, Forrest A, Gengo FM. Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration. J Clin Pharmacol 1997 37 : 711 718. (Pubitemid 27449280)
7. McCormick AS, Thomas VL, Berry D, Thomas PW. Plasma concentrations and sedation scores after nebulized and intranasal midazolam in healthy volunteers. Br J Anaesth 2008 100 : 631 636. (Pubitemid 351774376)
8. Romeo VD, deMeireles J, Sileno AP, Pimplaskar HK, Behl CR. Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Deliv Rev 1998 29 : 89 116.
9. Knoester PD, Jonker DM, Van Der Hoeven RT, Vermeij TA, Edelbroek PM, Brekelmans GJ, de Haan GJ. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers. Br J Clin Pharmacol 2002 53 : 501 507.
10. Wermeling DP, Record KA, Archer SM, Rudy AC. A pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulation. Epilepsy Res 2009 83 : 124 132.
11. Wermeling DP, Record KA, Kelly TH, Archer SM, Clinch T, Rudy AC. Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers. Anesth Analg 2006 103 : 344 349. (Pubitemid 44140633)
12. Dale O, Nilsen T, Loftsson T, Hjorth Tonnesen H, Klepstad P, Kaasa S, Holand T, Djupesland PG. Intranasal midazolam: a comparison of two delivery devices in human volunteers. J Pharm Pharmacol 2006 58 : 1311 1318. (Pubitemid 44580561)
13. Gudmundsdottir H, Sigurjonsdottir JF, Masson M, Fjalldal O, Stefansson E, Loftsson T. Intranasal administration of midazolam in a cyclodextrin based formulation: bioavailability and clinical evaluation in humans. Die Pharmazie 2001 56 : 963 966. (Pubitemid 34016828)
14. Loftsson T, Gudmundsdottir H, Sigurjonsdottir JF, Sigurdsson HH, Sigfusson SD, Masson M, Stefansson E. Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. Int J Pharm 2001 212 : 29 40. (Pubitemid 32121948)
15. Roelofse JA, Payne PK, Morkel JA, Penkler L, Malan J. Intranasal midazolam spray in adults-pharmacokinetics and clinical use. S Afr J Anesth Analg 2000 6 : 16 19.
16. Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev 2004 3 : 1023 1035. (Pubitemid 39642365)
17. Carrier RL, Miller LA, Ahmed I. The utility of cyclodextrins for enhancing oral bioavailability. J Control Release 2007 123 : 78 99. (Pubitemid 47566400)
18. Masson M, Loftsson T, Masson G, Stefansson E. Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. J Control Release 1999 59 : 107 118. (Pubitemid 29187198)
19. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res 1998 15 : 1326 1331. (Pubitemid 28427917)
20. Soane RJ, Hinchcliffe M, Davis SS, Illum L. Clearance characteristics of chitosan based formulations in the sheep nasal cavity. Int J Pharm 2001 217 : 183 191. (Pubitemid 32268644)
21. Dodane V, Amin Khan M, Merwin JR. Effect of chitosan on epithelial permeability and structure. Int J Pharm 1999 182 : 21 32. (Pubitemid 29229791)
22. Davis SS, Illum L. Absorption enhancers for nasal drug delivery. Clin Pharmacokinet 2003 42 : 1107 1128. (Pubitemid 37357648)
23. Illum L, Watts P, Fisher AN, Hinchcliffe M, Norbury H, Jabbal-Gill I, Nankervis R, Davis SS. Intranasal delivery of morphine. J Pharmacol Exp Ther 2002 301 : 391 400. (Pubitemid 34250318)
24. Dussy FE, Hamberg C, Briellmann TA. Quantification of benzodiazepines in whole blood and serum. Int J Legal Med 2006 120 : 323 330. (Pubitemid 44630570)
25. Schachinger H, Cox D, Linder L, Brody S, Keller U. Cognitive and psychomotor function in hypoglycemia: response error patterns and retest reliability. Pharmacol Biochem Behav 2003 75 : 915 920. (Pubitemid 37289478)
26. Penkler LJ, Whittaker D, Worthington M, Reyneke-Barnard C, Roelofse J. Intranasal midazolam: pre-formulation, formulation and pilot clinical experience [Abstract]. Published in the online journal of the American Association of Pharmaceutical Scientists (AAPS) on September 19, 2007. Available at http://www.aapsj.org/abstracts/AM-1999/652.htm.
27. Persson MP, Nilsson A, Hartvig P. Relation of sedation and amnesia to plasma concentrations of midazolam in surgical patients. Clin Pharmacol Ther 1988 43 : 324 331. (Pubitemid 18091855)